How to manage nausea associated with Atomoxetine (Strattera)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 16, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

To manage nausea from atomoxetine, taking the medication with food and starting with a lower dose are crucial steps, as evidenced by the common adverse effects of atomoxetine, including nausea, reported in clinical trials 1. When managing nausea from atomoxetine, several strategies can be employed to mitigate this side effect.

  • Taking the medication with food rather than on an empty stomach can significantly reduce gastrointestinal side effects, as food can slow down the absorption of atomoxetine and reduce its peak plasma concentration 1.
  • Starting with a lower dose, as recommended by the doctor, and gradually increasing it allows the body time to adjust to the medication, potentially reducing the severity of nausea.
  • Ensuring adequate hydration throughout the day is also important, as dehydration can exacerbate nausea.
  • Taking atomoxetine in the evening instead of the morning may help if the patient sleeps through the worst of the nausea.
  • Over-the-counter remedies like ginger supplements (250-500mg), ginger tea, or peppermint tea can provide relief from nausea, although their effectiveness may vary from person to person.
  • Simple dietary adjustments, such as eating smaller, more frequent meals and avoiding spicy, greasy foods, can also help alleviate nausea. It is essential to note that nausea is a common adverse effect of atomoxetine, affecting a significant portion of patients, especially during the initial treatment phase 1. If nausea persists despite these measures, it is crucial to consult a healthcare provider, as they might recommend anti-nausea medications, adjust the atomoxetine dosage, or consider alternative ADHD treatments 1. Nausea typically improves within 2-4 weeks as the body adapts to the medication, but persistent or severe symptoms should always be reported to the doctor 1.

From the FDA Drug Label

The most commonly observed adverse reactions in patients treated with atomoxetine hydrochloride (incidence of 5% or greater and at least twice the incidence in placebo patients, for either BID or QD dosing) were: nausea, vomiting, fatigue, decreased appetite, abdominal pain, and somnolence Nausea 10% The most commonly observed adverse reactions in patients treated with atomoxetine hydrochloride (incidence of 5% or greater and at least twice the incidence in placebo patients) were: constipation, dry mouth, nausea, decreased appetite, dizziness, erectile dysfunction, and urinary hesitation

Management of Nausea from Atomoxetine:

  • No specific guidance is provided in the label for managing nausea associated with atomoxetine use.
  • However, it can be inferred that nausea is a common side effect, and monitoring and supportive care may be necessary.
  • The label does not provide explicit instructions for managing nausea, so clinical judgment should be used to determine the best course of action 2.

From the Research

Managing Nausea from Atomoxetine

  • Nausea is a common adverse event associated with atomoxetine, reported significantly more frequently than with placebo 3, 4
  • The exact mechanism of nausea induced by atomoxetine is not well understood, but it may be related to its effects on the noradrenergic system
  • Studies on managing nausea in general, not specifically related to atomoxetine, suggest that ondansetron and metoclopramide may be effective antiemetics 5, 6
  • However, there is no direct evidence to support the use of these medications specifically for nausea induced by atomoxetine
  • Atomoxetine's pharmacokinetics and pharmacogenomics may play a role in its disposition and the resulting nausea, with variations in CYP2D6 expression affecting its metabolism 7
  • Dosage adjustments based on pharmacokinetic principles may be necessary to minimize nausea and other adverse events, but more research is needed to determine the optimal approach
  • Patients experiencing nausea while taking atomoxetine should consult their healthcare provider for guidance on managing this side effect, as individualized treatment approaches may be necessary

Related Questions

What are the recommended non-stimulant (Non-Stimulant) medication options for adults with Attention Deficit Hyperactivity Disorder (ADHD)?
Can an 82-year-old female with a history of previous myocardial infarction (PMX) stroke, brain aneurysm, diabetes mellitus (DM), menorrhagia, cholecystectomy, colon polyps, and tubal ligation, who has not responded to Zofran (ondansetron) for nausea, be given an alternative antiemetic medication?
Can a 10-year-old patient on 18mg of Strattera (atomoxetine) be increased to 36mg?
What is the recommended approach for adding Strattera (atomoxetine) as an adjunctive treatment for patients with Attention Deficit Hyperactivity Disorder (ADHD) who are not responding adequately to their current stimulant medication?
What are attention deficit hyperactivity disorder (ADHD) medications with less risk of abuse?
Are pears a suitable food for a 7-month-old infant?
What patient education is required post-operatively for a 51-year-old male patient who underwent surgery for right hand carpal tunnel release, cubital tunnel release, and trigger finger repair yesterday?
What is the cause of right first digit nail pain for 2 weeks, due to onychoschizia (nail splitting) and onycholysis (nail lifting from the nail bed), resulting in nail discoloration?
When to administer methimazole in patients with hyperthyroidism (Hyperthyroidism) and supraventricular tachycardia (SVT) and atrial flutter?
What is the differential diagnosis of bilateral chest wall hyperesthesia (increased sensitivity)?
What is the evaluation and management of a suspected small mass on the lateral aspect of the right tibia (tib)-fibula (fib), given a non-vascular ultrasound (u/s) result showing no masses?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.